The Irvine, California-based company designed LiDCO BIC to connect to multi-patient monitoring platforms, such as the Masimo Root Patient Monitoring and Connectivity Hub. It allows clinicians to easily add LiDCO hemodynamic monitoring with the company’s versatile PulseCO algorithm to its Root patient monitoring hubs.
LiDCO is pressure transducer agnostic and enables hemodynamic monitoring alongside other supported parameters without having a dedicated hemodynamic monitoring box. The module supports everything from powerful guided protocols to assess fluid responsiveness to rich trending data and notifications for beat-by-beat pressure analysis that can be displayed in helpful configurations for each patient, according to Masimo.
“Bringing LiDCO’s beat-to-beat advanced hemodynamic monitoring to Masimo Root opens up the possibility of providing a more complete, continuous picture of cardiac output (CO) and oxygen delivery (DO2). Currently, hemodynamic monitors can provide continuous analysis of blood pressure information but rely on intermittent data from other monitors for oxygenation – giving clinicians only half of the information,” CEO and Founder Joe Kiani said in a news release.
More about how LiDCO works
The LiDCO module was designed for efficient setup and simple, versatile operation. It uses a patient’s existing arterial line and blood pressure transducer to monitor a large list of advanced hemodynamic parameters using the company’s beat-by-beat PulseCO algorithm. The beat-by-beat analysis helps to provide more immediate feedback on fluid and hemodynamic status and avoids delays common with other hemodynamic monitors that rely on assumptions about vascular compliance or detection of the dicrotic notch. Its board-in-cable design takes into account seamless compatibility with the Root monitor and other multi-parameter platforms to remove the need for a dedicated hemodynamic monitor.
“The introduction of the Masimo LiDCO Module is clinically very exciting, as it will deliver dynamic hemodynamic monitoring, with a known documented positive impact on patient outcome. The ability to provide individualized goal-directed therapy with calculated global oxygen delivery using LiDCO-derived cardiac output is clinically important. In my opinion, understanding the individualized physiology of a particular patient is paramount to targeted treatments. Assessing preload, contractility, and afterload using the LiDCO algorithm underpins patient management and the enhanced recovery after surgery (ERAS) process,” said Dr. Max Jones, a consultancy in intensive care medicine and anesthesia at Southampton General Hospital in the U.K.
In clinical studies, Masimo said LiDCO has been shown to reduce post-operative complications, costs and mortalities at 30 and 180 days after surgery. In a randomized, controlled trial of 743 patients undergoing major abdominal surgery, researchers found hemodynamic optimization with LiDCO led to a 20% reduction in postoperative complications, and patients monitored with LiDCO were on average $530 less expensive to treat than control patients who were not monitored. Masimo said another study that compared the outcomes of 600 emergency laparotomy patients, researchers found that there was a significant decrease in mortality at 30 days and 180 days following the implementation of a program using LiDCO technology.
“The LiDCO monitor offers several advantages in hemodynamic monitoring. It is a plug-and-play solution, directly connected to the patient monitor or existing blood pressure transducer, without any disposables, compatible with various patient monitoring systems, helping healthcare providers to make better decisions,” said Dr. Daniela Chaló, Head of Anesthesiology at Centro Hospitalar Baixo Vouga in Portugal. “The addition of LiDCO to the Root monitor – which also offers SpHb for hemoglobin monitoring and SedLine and O3 for brain monitoring – means that all pertinent information can be available on one sole monitor. This is an extraordinary advancement for anesthesiology and intensive care. Root raises the standard of perioperative monitoring and is even bringing it to the artificial intelligence era. This is what we have all been waiting for.”
